Groesser et al. demonstrate that pyogenic granuloma is a RAS pathway-driven tumor. This important observation adds yet another manifestation to the growing spectrum of cutaneous "RASopathies" and raises intriguing questions about the relationship between RAS pathway activation and malignancy.
|Number of pages||2|
|Journal||Journal of Investigative Dermatology|
|Early online date||20 Jan 2016|
|Publication status||Published - Feb 2016|